Question 1

Does AQR Capital Management own ANRO stock?

Accepted Answer

No. AQR Capital Management exited its ANRO (Alto Neuroscience) position in Q4 2025. Its Q3 2025 13F listed 30,412 shares worth $122,256.

Question 2

How many shares of ANRO does AQR Capital Management own?

Accepted Answer

None since Q4 2025, when AQR Capital Management exited the position. Its Q3 2025 13F listed 30,412 shares worth $122,256.

Question 3

What is AQR Capital Management's ANRO position worth?

Accepted Answer

AQR Capital Management's ANRO position was worth $122,256 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is AQR Capital Management buying or selling ANRO?

Accepted Answer

In Q4 2025, AQR Capital Management exited its entire ANRO position.

Question 5

When did AQR Capital Management first buy ANRO?

Accepted Answer

AQR Capital Management first reported ANRO in its Q1 2025 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$17.80	0
2025-Q3	Decreased	30,412	-60.3%	$122,256	0.0%	$4.02	0
2025-Q2	Increased	76,512	+217.5%	$168,326	0.0%	$2.20	36
2025-Q1	New	24,099	—	$52,054	0.0%	$2.16	29